XERS FY 2021 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$960M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M+142.7% YoY

Gross Profit

$36M73.1% margin

Operating Income

-$115M-232.2% margin

Net Income

-$123M-247.5% margin

EPS (Diluted)

$-1.55

Cash Flow

Operating Cash Flow

-$103M

Free Cash Flow

-$103M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$304M

Total Liabilities

$209M

Stockholders' Equity

$95M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$20M	+142.7%
Gross Profit	$36M	$11M	+226.6%
Operating Income	-$115M	-$84M	-37.8%
Net Income	-$123M	-$91M	-34.7%